Cancer Funding To Defense Dept. Is Threat To National Cancer Program, Broder Says
In Brief: Columiba Adds Presbyterian to Center’s Name: Clinton’s Mother Honored; DeVita move Rumored
NIH Director Healy Resigned, To Return To Cleveland In June’ Kessler To Remain
Sen. Pryor Attacks Drug Industry, NIH Technology Transfer
Clinton Names Broadnax HHS Deputy, Others to Sub-Cabinet Posts
Trial Needed Of PSA To Determine Patients To Test, Chabner Says
DCT Advisors Okay PA In Imaging Patters Of Care RFA; Contracts
IOM Calls FDA Advisory System Sounds, Suggests Conflict Criteria Changes
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Cancer patients with Medicare Advantage have access to fewer providers than Medicare patients, cross-sectional study finds
- A chronotherapy study in Nature Medicine showed dramatic results. Then it was retracted.
The phase III trial claimed a staggering boost to OS and PFS when immunochemotherapy was given before 3 p.m. - Did peer review fail? Nature Medicine’s chronotherapy paper retraction raises questions
- A new diagnostic lens—and a lasting scientific legacy
- OMB’s plan to increase political control of science faces stiff opposition on Capitol Hill









